Salbutamol, also referred as albuterol, is a member of the bronchodilator family. It is used to prevent and treat difficulty in wheezing, shortness of breath, chest tightness, and coughing caused by lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. It acts by inhibiting the cells, particularly mast cells, from releasing acute hypersensitivity mediators. Salbutamol has a minor effect on beta-1 adrenergic receptors, which has little effect on heart rate. It works by relaxing the muscles surrounding your airways, so that they open up and you can breathe more easily.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global salbutamol sulphate market.
Top Impacting Factors
Increasing prevalence of respiratory diseases across the world helps to boost the growth of the salbutamol sulphate market. Adoption of sedentary lifestyle, increase in geriatric population, rise in number of FDA approval drugs, increase in patient awareness are some factors, which boost market growth of the salbutamol sulfate market.
In addition, increase in healthcare expenditure, rise in research & development activities conducted by many pharmaceutical companies, launches of novel developed drug in market are some drivers of neurological disorder drugs market.
However, salbutamol sulphate has certain side effects, which restrain the market growth of the salbutamol sulphate market.
Market Trends
New Product Launches to Flourish the Market
In May 2020, Lupin announced that it has received US Food and Drug Administration (USFDA) approval for its Albuterol Sulfate inhalation aerosol which is a generic version of proair. Albuterol MDI is a key rescue inhalation product for asthma patients.
In April 2020, Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation Aerosol used in the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.
Surge in Usage of Salbutamol Sulphate
Increasing prevalence of respiratory diseases such as asthma or chronic obstructive pulmonary disease ( COPD ) helps to boost the usage of salbutamol sulphate. Increase in the awareness of respiratory diseases may surge the usage of the salbutamol sulphate.
Key Benefits of the Report
- This study presents the analytical depiction of the market salbutamol sulfate market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the drugs market share.
- The current market is quantitatively analyzed to highlight market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Salbutamol Sulfate Market Report
- Which are the leading market players active in the salbutamol sulfate market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What future projections would help in taking further strategic?
- What is salbutamol sulfate market?
- What is salbutamol sulfate market prediction in the future?
- Who are the leading global players in the salbutamol sulfate market?
- What are the current trends and predicted trends?
- What are the key benefits of the salbutamol sulfate market report?
Salbutamol Sulfate Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | GlaxoSmithKline PLC., Akron Inc., Sun Pharmaceutical Industries Ltd., Amneal pharmaceutical Inc, Cipla Inc., Mylan N.V., Aurobindo, SUNOVION, Kindeva Drug Delivery, Teva Pharmaceuticals Industries Ltd. |
Loading Table Of Content...
